A new oral GLP-1 medication can help adults with obesity and type 2 diabetes lose more weight and improve their blood sugar levels compared to a placebo, according to findings from the ATTAIN-2 trial ...

Credit: Novo Nordisk. Wegovy tablets offer a daily oral alternative to injections for weight reduction and reducing cardiovascular risk in eligible adult patients. The Wegovy tablet is now available ...

Obesity is a major risk factor for many leading causes of illness and death worldwide. Data are needed regarding the efficacy and safety of the nonpeptide glucagon-like peptide-1 (GLP-1) receptor ...

A daily pill could soon challenge monthly depot injections as standard therapy for acromegaly in Europe. At its February meeting, the European Medicines Agency’s (EMA’s) Committee for Medicinal ...

Among people with a previous heart attack or stroke, or who are at high risk for one, a daily oral medication may offer an effective alternative to injections of PCSK9 inhibitors to lower low-density ...

Please provide your email address to receive an email when new articles are posted on . Daily oral semaglutide was tied to more weight loss vs. placebo plus lifestyle interventions in people with ...